Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
The FDA approved semaglutide for chronic weight management in adults with obesity (BMI 30+) or overweight (BMI 27+) with at least one weight-related condition like hypertension, high cholesterol, or type 2 diabetes
The glucagon receptor component of retatrutide raises specific safety questions that require further investigation
Having allies who understand your goals and can support your decisions makes a meaningful difference
Phase 3 (Weeks 13, 20): Maintenance and reassessment
US$ 20.82
US$ 22.01
US$ 28.83
